|Articles|December 10, 2011
Video blog: HER2-targeted agents
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Trodelvy Plus Keytruda Shows Lasting Benefit in Metastatic Breast Cancer
2
Oncologist Answers Most Asked Questions About Colorectal Cancer
3
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care
4
Medical Cannabis Education Improves Oncology Nurses’ Confidence in Patient Discussions
5